Literature DB >> 8533409

Neuroendocrine disorders of the gut.

L F Yee1, S J Mulvihill.   

Abstract

The regulation of gastrointestinal function is known to involve elements of the enteric nervous system. Processes such as secretion, motility, blood flow, and immune function are all influenced by a complex network of neurons whose cell bodies lie in the gut. These neurons use a wide spectrum of substances as neurotransmitters, although the majority use peptides once thought to function only as gut hormones. It has been increasingly recognized that abnormalities of this neuroendocrine regulatory system underlie many gastrointestinal disorders. The most obvious are states of peptide excess found in patients with gut endocrine tumors such as carcinoid, gastrinoma, and somatostatinoma. Conversely, other disorders appear to be related to deficiency states. Examples include both achalasia and Hirschsprung's disease (congenital megacolon), where the loss of inhibitory neural action leads to abnormalities of peristalsis and sphincter function. Evidence for abnormal neuroendocrine regulation leading to disease states is increasing for many other gastrointestinal disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533409      PMCID: PMC1303170     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  43 in total

1.  Enhanced mucosal cytokine production in inflammatory bowel disease.

Authors:  W E Pullman; S Elsbury; M Kobayashi; A J Hapel; W F Doe
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

2.  Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.

Authors:  R F Harvey; A E Read
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

3.  Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

Authors:  N A Wright; R Poulsom; G Stamp; S Van Noorden; C Sarraf; G Elia; D Ahnen; R Jeffery; J Longcroft; C Pike
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

4.  Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia.

Authors:  W J Dodds; J Dent; W J Hogan; G K Patel; J Toouli; R C Arndorfer
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

5.  Somatostatin-receptor imaging in the localization of endocrine tumors.

Authors:  S W Lamberts; W H Bakker; J C Reubi; E P Krenning
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

6.  Interdigestive motor activity in patients with systemic sclerosis.

Authors:  W D Rees; R J Leigh; N D Christofides; S R Bloom; L A Turnberg
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

7.  Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.

Authors:  I Virgolini; M Raderer; A Kurtaran; P Angelberger; S Banyai; Q Yang; S Li; M Banyai; J Pidlich; B Niederle; W Scheithauer; P Valent
Journal:  N Engl J Med       Date:  1994-10-27       Impact factor: 91.245

8.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

9.  Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea.

Authors:  M R von der Ohe; M Camilleri; L K Kvols; G M Thomforde
Journal:  N Engl J Med       Date:  1993-10-07       Impact factor: 91.245

10.  Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia.

Authors:  S Aggestrup; R Uddman; F Sundler; J Fahrenkrug; R Håkanson; H R Sørensen; G Hambraeus
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

View more
  2 in total

1.  Gut hormones. Yesterday, today, and tomorrow.

Authors:  S J Mulvihill
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

2.  Chemical messengers of the gut.

Authors:  R A Liddle
Journal:  West J Med       Date:  1995-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.